N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia von Kantrowitz, Joshua T.

Volltext

The Potential Role of Lumateperone—Something Borrowed? Something New? von Kantrowitz, Joshua T

Volltext

Managing Negative Symptoms of Schizophrenia: How Far Have We Come? von Kantrowitz, Joshua T.

Volltext

N-methyl- d -aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia? von Kantrowitz, Joshua T, Javitt, Daniel C

Volltext

Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia von Javitt, Daniel C., Lee, Migyung, Kantrowitz, Joshua T., Martinez, Antigona

Volltext

D-Serine: A Cross Species Review of Safety von Meftah, Amir, Hasegawa, Hiroshi, Kantrowitz, Joshua T.

Volltext

Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine von Kantrowitz, Joshua T, Epstein, Michael L, Beggel, Odeta, Rohrig, Stephanie, Lehrfeld, Jonathan M, Revheim, Nadine, Lehrfeld, Nayla P, Reep, Jacob, Parker, Emily, Silipo, Gail, Ahissar, Merav, Javitt, Daniel C

Volltext

Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder von Kantrowitz, Joshua T., Dong, Zhengchao, Milak, Matthew S., Rashid, Rain, Kegeles, Lawrence S., Javitt, Daniel C., Lieberman, Jeffrey A., John Mann, J.

Volltext

Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings von Poels, Eline M.P, Kegeles, Lawrence S, Kantrowitz, Joshua T, Javitt, Daniel C, Lieberman, Jeffrey A, Abi-Dargham, Anissa, Girgis, Ragy R

Volltext

Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharm... von Kantrowitz, Joshua T, Grinband, Jack, Goff, Donald C, Lahti, Adrienne C, Marder, Stephen R, Kegeles, Lawrence S, Girgis, Ragy R, Sobeih, Tarek, Wall, Melanie M, Choo, Tse-Hwei, Green, Michael F, Yang, Yvonne S, Lee, Junghee, Horga, Guillermo, Krystal, John H, Potter, William Z, Javitt, Daniel C, Lieberman, Jeffrey A

Volltext

A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia von Lee, Migyung, Sehatpour, Pejman, Dias, Elisa C., Silipo, Gail S., Kantrowitz, Joshua T., Martinez, Antigona M., Javitt, Daniel C.

Volltext

D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanis... von Kantrowitz, Joshua T, MD, Woods, Scott W, Prof, Petkova, Eva, PhD, Cornblatt, Barbara, Prof, Corcoran, Cheryl M, MD, Chen, Huaihou, PhD, Silipo, Gail, MS, Javitt, Daniel C, Prof

Volltext

Neurophysiological Effects of Bitopertin in Schizophrenia von Kantrowitz, Joshua T, Nolan, Karen A, Epstein, Michael L, Lehrfeld, Nayla, Shope, Constance, Petkova, Eva, Javitt, Daniel C

Volltext

d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine von Kantrowitz, Joshua T, Milak, Matthew S, Mao, Xiangling, Shungu, Dikoma C, Mann, J John

Volltext

Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study von Girgis, Ragy R., Baker, Seth, Mao, Xiangling, Gil, Roberto, Javitt, Daniel C., Kantrowitz, Joshua T., Gu, Meng, Spielman, Daniel M., Ojeil, Najate, Xu, Xiaoyan, Abi-Dargham, Anissa, Shungu, Dikoma C., Kegeles, Lawrence S.

Volltext

Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions von Kantrowitz, Joshua T.

Volltext

Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement von Sehatpour, Pejman, Kantrowitz, Joshua T.

Volltext

Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study von Dong, Zhengchao, Grunebaum, Michael F, Lan, Martin J, Wagner, Vashti, Choo, Tse-Hwei, Milak, Matthew S, Sobeih, Tarek, Mann, J John, Kantrowitz, Joshua T

Volltext

Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches von Kantrowitz, Joshua T.

Volltext

Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia von Sehatpour, Pejman, Avissar, Michael, Kantrowitz, Joshua T, Corcoran, Cheryl M, De Baun, Heloise M, Patel, Gaurav H, Girgis, Ragy R, Brucato, Gary, Lopez-Calderon, Javier, Silipo, Gail, Dias, Elisa, Martinez, Antigona, Javitt, Daniel C

Volltext